{
  "cui": "C1266147",
  "cui_name": "Neuroendocrine tumor grade 1",
  "incidence_per_100k": 2.5,
  "prevalence_per_100k": null,
  "metric_type": "incidence",
  "total_cases_per_year": 200000,
  "confidence": 0.6,
  "is_subtype": true,
  "parent_disease": "Neuroendocrine Neoplasm",
  "reasoning": "Grade 1 (low-grade) NET represents ~25-30% of all NETs. Global NET incidence estimated 2-5 per 100k, with grade 1 representing lower end at ~2.5 per 100k.",
  "data_quality": "moderate",
  "geographic_variation": "moderate",
  "year_specific": false,
  "data_year": null,
  "source": "Yao JC et al. (2008). One hundred years after 'carcinoid': epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 26(18):3063-3072",
  "source_url": "https://pubmed.ncbi.nlm.nih.gov/18565894/",
  "source_type": "literature"
}
